Avi Polymers plans to diversify into the fast-growing Healthcare Technology sector through its subsidiary, AVI AI Technologies.
The Board of Directors will meet next Monday to consider and approve a strategic diversification.
The initiative is aimed at leveraging emerging opportunities at the intersection of artificial intelligence and healthcare, with a focus on building scalable, innovation-led solutions.
The Board will deliberate on a comprehensive strategic roadmap and capital allocation plan to enable this entry into healthcare technology. This move reflects the company’s vision to establish a diversified, AI-driven digital ecosystem that complements its existing business operations while unlocking new growth avenues.
The proposed expansion comes at a time when healthcare technology is witnessing rapid transformation, driven by increased adoption of digital platforms, data-driven decision-making and AI-powered diagnostics and services.
This apartment, the Board will approve the Audited Financial Results and consider recommending a dividend of up to 50 per cent on the paid-up equity share capital for the financial year 2025–26.
Chintan Patel, Managing Director, AVI Polymers said the Board believes that this strategic foray will not only enhance the company’s growth prospects but also strengthen its ability to create value for stakeholders through innovation and diversification.
Further details on the strategic roadmap and implementation plans are expected to be shared after the Board meeting, he said.
The company has recently launched ‘KrishiBuddy’, an AI-powered smart farming platform developed by its wholly owned subsidiary AVI Eco Spark.